n.22

COP 16: Pharma and agritech groups against biodiversity tax at UN summit


Negotiators are discussing an agreement at the ongoing COP16 UN biodiversity summit in Colombia on payment for the use of data known as digital sequence information (DSI), which is heavily used by manufacturers of drugs and agricultural products. Companies ranging from AstraZeneca and GSK to Bayer access the information mostly for free, but nations agreed at the last COP15 summit to set up a multilateral fund for 'benefit sharing' from its use. The most controversial option, put forward by a group of African nations, would impose a levy of 1% of the retail value of all products made with ISD. The German pharmaceutical and agricultural conglomerate Bayer has argued that the additional cost to companies could translate into higher prices for food and other products

n.18

7-Eleven will build 500 ‘food-forward’ shops between 2025 and 2027, giving up the sale of non-food products (including petrol)


These shops will expand the 'hot food assortment that our customers are looking for, with take-away cases, specialty beverages, self-service roller grills, and in-store cooking offerings'. 7-Eleven operates, franchises or licenses more than 83,000 convenience stores in 19 countries and regions, including approximately 13,229 locations in the United States and Canada. Already today, 7-Eleven shops look like convenience stores, even in Japan.